Evidence map›Paper›PMID 35279203›Full record

ArticleStem cell research & therapy2022

Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture.

Saeko Akiyama, Noriaki Saku, Shoko Miyata, Kenta Ite, Masashi Toyoda, Tohru Kimura, Masahiko Kuroda, Atsuko Nakazawa, Mureo Kasahara, Hidenori Nonaka and 5 more

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Saeko AkiyamaCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Noriaki SakuCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Shoko MiyataCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Kenta IteCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Masashi ToyodaCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Tohru KimuraLaboratory of Stem Cell Biology, Department of BioSciences, Kitasato University School of Science, Kanagawa, Japan.
Masahiko KurodaDepartment of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, Japan.
Atsuko NakazawaCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Mureo KasaharaOrgan Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
Hidenori NonakaCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Akihide KamiyaDepartment of Molecular Life Sciences, Tokai University School of Medicine, Kanagawa, Japan.
Tohru KiyonoProject for Prevention of HPV-Related Cancer, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
Tohru KobayshiDepartment of Data Science, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
Yasufumi MurakamiTokyo University of Science, Tokyo, Japan.
Akihiro UmezawaCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan. umezawa@1985.jukuin.keio.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, hardly expandable in vitro making it difficult to secure large numbers of cells from one donor. Alternatively, systems using animal models and hepatocellular carcinoma cells have been established, but interspecies differences, variation between human cell sources and limited hepatic functions are among the challenges faced when using these models. Therefore, there is still a need for a highly stable method to purify human hepatocytes with functional sufficiency. In this study, we aimed to establish an in vitro long-term culture system that enables stable proliferation and maintenance of human hepatocytes to ensure a constant supply.

methodsWe first established a growth culture system for hepatocytes derived from patients with drug-induced liver injury using fetal mouse fibroblasts and EMUKK-05 medium. We then evaluated the morphology, proliferative capacity, chromosome stability, gene and protein expression profiles, and drug metabolic capacity of hepatocytes in early, middle and late passages with and without puromycin. In addition, hepatic maturation in 3D culture was evaluated from morphological and functional aspects.

resultsIn our culture system, the stable proliferation of human hepatocytes was achieved by co-culturing with mouse fetal fibroblasts, resulting in dedifferentiation into hepatic progenitor-like cells. We purified human hepatocytes by selection with cytocidal puromycin and cultured them for more than 60 population doublings over a span of more than 350 days. Hepatocytes with high expression of cytochrome P450 genes survived after exposure to cytocidal antibiotics because of enhanced drug-metabolizing activity.

conclusionsThese results show that this simple culture system with usage of the cytocidal antibiotics enables efficient hepatocyte proliferation and is an effective method for generating a stable supply of hepatocytes for drug discovery research at a significant cost reduction.

Indexed as

Chemical and Drug Induced Liver InjuryHepatocytesAnimalsCell ProliferationCells, CulturedCytochrome P-450 Enzyme SystemHumansLiverMiceCytochrome P-450 Enzyme SystemCytochrome P450Drug discoveryDrug-induced liver injuryHepatocytesLiver regeneration

Identifiers

PMID35279203
PMCPMC8917760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.